Skip to main content

GOLDMAN SACHS GROUP INC

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 886982 NEW YORK, NY

Position in JAZZ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$67,434,008
+$20,110,824 QoQ
Shares Held
279,844
+11.8% QoQ
Ownership
0.431%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#45
of 643 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in JAZZ Over Time

Shares Held

Position Value (USD)

Derivatives in JAZZ

reported options exposure · as of Dec 31, 2025
CallValue
$1,598,000
CallShares
9,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. JAZZ ranks #51 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in JAZZ

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67,434,008 279,844
2026-03-31 $47,323,184 250,321
2025-12-31 $29,661,090 174,477
2025-12-31 $1,598,000 9,400
2025-09-30 $21,755,962 165,068
2025-06-30 $27,868,597 262,614
2025-03-31 $43,652,256 351,609
2024-12-31 $17,480,156 141,942
2024-09-30 $16,162,470 145,072
2024-06-30 $20,275,391 189,969
2024-03-31 $22,441,952 186,364
2023-12-31 $29,338,206 238,522
2023-09-30 $39,128,933 302,294
2023-06-30 $34,017,242 274,399
2023-03-31 $40,031,351 273,569
2022-12-31 $70,731,567 443,987
2022-09-30 $102,251,155 767,133
2022-06-30 $151,701,158 972,381
2022-03-31 $165,357,187 1,062,229
2021-12-31 $166,986,874 1,310,729
2021-09-30 $23,126,336 177,608
2021-06-30 $54,396,209 306,216
2021-03-31 $87,820,424 534,285
2021-03-31 $18,902,550 115,000
2020-12-31 $95,683,445 579,724
2020-09-30 $49,024,723 343,816
2020-06-30 $62,855,070 569,649
2020-03-31 $64,366,210 645,340